467(top 0.1%)
PR articles
43.7K(top 0.1%)
PR citations
93(top 0.1%)
PR h-index
103(top 0.1%)
h-index
632
documents
55.7K
doc citations
5.1K
citing journals
100
times ranked

Publications

503 peer-reviewed articles • 47,054 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Falling through the cracks: what happens to survivors of preterm birth?
ERJ Open Research, 2025, 11, 00643-2024
2.56Citations (PDF)
2Fractional exhaled nitric oxide in a respiratory healthy general population through the lifespan
Pulmonology, 2025, 31,
2.311Citations (PDF)
3Heterogeneity of reduced FEV1 in early adulthood: A looking forward, looking backwards analysis
Respirology, 2025, 30, 326-334
4.011Citations (PDF)
4Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?
ERJ Open Research, 2025, 11, 00793-2024
2.53Citations (PDF)
5Treatable Trait Guided Asthma Management: A Feasibility Study
Respirology, 2025, 30, 480-492
4.03Citations (PDF)
6Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study
Npj Primary Care Respiratory Medicine, 2025, 35,
3.99Citations (PDF)
7Alteraciones espirométricas y sus factores de riesgo en la población joven ambulatoria
Medicina Clínica, 2025, 164, 106910
0.80Citations (PDF)
8Spirometric alterations and their risk factors in young ambulatory population
Medicina Clínica (English Edition), 2025, 164, 106910
0.10Citations (PDF)
9Asthma and obstructive sleep apnea: A complex but treatable relationship
Sleep Medicine Reviews, 2025, 83, 102146
8.72Citations (PDF)
10Towards early detection and disease interception of COPD across the lifespan
European Respiratory Review, 2025, 34, 240243
8.27Citations (PDF)
11A person-centred clinical approach to the multimorbid patient with COPD
European Journal of Internal Medicine, 2025, 140, 106424
2.716Citations (PDF)
12Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
American Journal of Respiratory and Critical Care Medicine, 2024, 209, 390-401
8.936Citations (PDF)
13From treatable traits to GETomics in airway disease: moving towards clinical practice
European Respiratory Review, 2024, 33, 230143
8.219Citations (PDF)
14Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Journal of Allergy and Clinical Immunology: in Practice, 2024, 12, 824-837
3.333Citations (PDF)
15Epigenome-Wide Association Studies of Chronic Obstructive Pulmonary Disease and Lung Function: A Systematic Review
American Journal of Respiratory and Critical Care Medicine, 2024, 210, 766-778
8.914Citations (PDF)
16Early Life Exposures and the Development of Chronic Obstructive Pulmonary Disease across the Life Course
American Journal of Respiratory and Critical Care Medicine, 2024, 210, 572-580
8.921Citations (PDF)
17Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
Respirology, 2024, 29, 551-562
4.022Citations (PDF)
18Association of Preserved Ratio Impaired Spirometry with Arterial Stiffness
Annals of the American Thoracic Society, 2024, 21, 1289-1298
3.410Citations (PDF)
19Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime
Respiratory Medicine, 2024, 233, 107779
2.61Citations (PDF)
20Managing and discharging COPD patients hospitalized because of an exacerbation of respiratory symptoms: An opportunity to improve outcomes
European Journal of Internal Medicine, 2024, 128, 20-22
2.71Citations (PDF)
21Lung function in young adults born small for gestational age at term
Respirology, 2023, 28, 183-186
4.05Citations (PDF)
22Circulating Biomarkers in Young Individuals with Low Peak FEV1
American Journal of Respiratory and Critical Care Medicine, 2023, 207, 354-358
8.911Citations (PDF)
23Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?
Respiratory Medicine, 2023, 206, 107070
2.62Citations (PDF)
24Treatable Traits in Airway Disease: From Theory to Practice
Journal of Allergy and Clinical Immunology: in Practice, 2023, 11, 713-723
3.377Citations (PDF)
25Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Respirology, 2023, 28, 316-338
4.030Citations (PDF)
26Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
ERJ Open Research, 2023, 9, 00020-2023
2.56Citations (PDF)
27Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review
Respiratory Medicine, 2023, 214, 107284
2.615Citations (PDF)
28Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
Journal of Allergy and Clinical Immunology: in Practice, 2023, 11, 2803-2811
3.38Citations (PDF)
29When GETomics meets aging and exercise in COPD
Respiratory Medicine, 2023, 216, 107294
2.617Citations (PDF)
30GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
European Respiratory Journal, 2023, 61, 2300616
8.716Citations (PDF)
31GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
Clinical Research in Cardiology, 2023, 113, 195-204
2.843Citations (PDF)
32Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan
Respirology, 2023, 28, 942-953
4.015Citations (PDF)
33Updated Definition of Chronic Obstructive Pulmonary Disease in the Global Initiative for Chronic Obstructive Lung Disease 2023 Executive Report: Expert Perspectives
US Respiratory & Pulmonary Diseases, 2023, 8, 9
0.20Citations (PDF)
34Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2023, 208, 1026-1041
8.970Citations (PDF)
35Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Nature Metabolism, 2023, 5, 2111-2130
17.1184Citations (PDF)
36A New and More Sensitive Method to Integrate the Desaturation Distance Ratio During a 6-Minute Walking Test in Chronic Respiratory Diseases: Physiological Correlates
Archivos De Bronconeumologia, 2022, 58, 188-190
1.45Citations (PDF)
37Specific miRNA Profile in Chronic Obstructive Pulmonary Disease Related to Biomass Smoke Exposure
Archivos De Bronconeumologia, 2022, 58, 177-179
1.43Citations (PDF)
38Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications
Allergy: European Journal of Allergy and Clinical Immunology, 2022, 77, 1105-1113
6.748Citations (PDF)
39Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward
American Journal of Respiratory and Critical Care Medicine, 2022, 205, 275-287
8.9159Citations (PDF)
40ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
European Respiratory Journal, 2022, 59, 2102006
8.754Citations (PDF)
41Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies
Lancet Respiratory Medicine,the, 2022, 10, 83-94
23.331Citations (PDF)
42The 7 Cardinal Sins of COPD in Spain
Archivos De Bronconeumologia, 2022, 58, 498-503
1.45Citations (PDF)
43Severe Pulmonary Hypertension in COPD
Chest, 2022, 162, 202-212
1.0102Citations (PDF)
44Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria
Respiratory Medicine, 2022, 192, 106726
2.628Citations (PDF)
45Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
European Respiratory Journal, 2022, 59, 2103036
8.717Citations (PDF)
46Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose
Archivos De Bronconeumologia, 2022, 58, 663-665
1.41Citations (PDF)
47Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
Respiratory Research, 2022, 23,
4.241Citations (PDF)
48Más alla del binomio EPOC-tabaco: nuevas oportunidades para la prevención y tratamiento precoz de la enfermedad
Medicina Clínica, 2022, 159, 33-39
0.86Citations (PDF)
49[Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia
Archivos De Bronconeumologia, 2022, 58, T444-T447
1.41Citations (PDF)
50Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan
Lancet Respiratory Medicine,the, 2022, 10, 512-524
23.3286Citations (PDF)
51Real-life burden of hospitalisations due to COPD exacerbations in Spain
ERJ Open Research, 2022, 8, 00141-2022
2.512Citations (PDF)
52Chronic Bronchial Infection Is Associated with More Rapid Lung Function Decline in Chronic Obstructive Pulmonary Disease
Annals of the American Thoracic Society, 2022, 19, 1842-1847
3.434Citations (PDF)
53Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review
American Journal of Respiratory and Critical Care Medicine, 2022, 206, 17-24
8.9141Citations (PDF)
54Beyond the COPD-tobacco binomium: New opportunities for the prevention and early treatment of the disease
Medicina Clínica (English Edition), 2022, 159, 33-39
0.11Citations (PDF)
55Treatable traits in the NOVELTY study
Respirology, 2022, 27, 929-940
4.070Citations (PDF)
56Contemporary Challenges in the Management of Asthma and Chronic Obstructive Pulmonary Disease: Expert Perspectives on Optimising Outcomes Through Guidelines Implementation, Inhaler Selection, and Patient Engagement
European Medical Journal Respiratory, 2022, , 31-42
0.10Citations (PDF)
57Inhaled corticosteroids for the treatment of COVID-19
European Respiratory Review, 2022, 31, 220099
8.215Citations (PDF)
58New Frontiers in Chronic Obstructive Pulmonary Disease: Where Are We Heading?
European Medical Journal Respiratory, 2022, , 2-10
0.11Citations (PDF)
59Bronchial Infection and Temporal Evolution of Bronchiectasis in Patients With Chronic Obstructive Pulmonary Disease
Clinical Infectious Diseases, 2021, 72, 403-410
5.249Citations (PDF)
60Treatable Traits That Predict Health Status and Treatment Response in Airway Disease
Journal of Allergy and Clinical Immunology: in Practice, 2021, 9, 1255-1264.e2
3.352Citations (PDF)
61Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2021, 203, 651-651
8.90Citations (PDF)
62From GOLD 0 to Pre-COPD
American Journal of Respiratory and Critical Care Medicine, 2021, 203, 414-423
8.9248Citations (PDF)
63Lung DNA Methylation in Chronic Obstructive Pulmonary Disease: Relationship with Smoking Status and Airflow Limitation Severity
American Journal of Respiratory and Critical Care Medicine, 2021, 203, 129-134
8.927Citations (PDF)
64Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
European Respiratory Journal, 2021, 58, 2003927
8.773Citations (PDF)
65Low birth weight as a potential risk factor for severe COVID-19 in adults
Scientific Reports, 2021, 11,
3.413Citations (PDF)
66Improving lung health in low-income and middle-income countries: from challenges to solutions
Lancet, The, 2021, 397, 928-940
62.1405Citations (PDF)
67Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
Archivos De Bronconeumologia, 2021, 57, 59-61
1.438Citations (PDF)
68Risk Factors and Relation with Mortality of a New Acquisition and Persistence of Pseudomonas aeruginosa in COPD Patients
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2021, 18, 333-340
2.027Citations (PDF)
69Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long‐term observational study
Respirology, 2021, 26, 776-785
4.015Citations (PDF)
70Cellular Senescence in Lung Fibrosis
International Journal of Molecular Sciences, 2021, 22, 7012
4.469Citations (PDF)
71Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health Study
ERJ Open Research, 2021, 7, 00020-2021
2.522Citations (PDF)
72Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases
European Journal of Internal Medicine, 2021, 89, 3-9
2.754Citations (PDF)
73Lung Function Levels Influence the Association between Obesity and Risk of COVID-19
American Journal of Respiratory and Critical Care Medicine, 2021, 204, 1106-1108
8.94Citations (PDF)
74COVID-19 diagnostic tests: Importance of the clinical context
Medicina Clínica (English Edition), 2021, 157, 185-190
0.18Citations (PDF)
75Pruebas diagnósticas COVID-19: importancia del contexto clínico
Medicina Clínica, 2021, 157, 185-190
0.87Citations (PDF)
76Is asthma associated with COVID-19 infection? A UK Biobank analysis
ERJ Open Research, 2021, 7, 00309-2021
2.510Citations (PDF)
77Moving towards a Treatable Traits model of care for the management of obstructive airways diseases
Respiratory Medicine, 2021, 187, 106572
2.654Citations (PDF)
78Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
European Respiratory Journal, 2021, 57, 2001339
8.743Citations (PDF)
79Estudio histológico mediante biopsia pulmonar post mortem en pacientes con neumonía por COVID-19
Archivos De Bronconeumologia, 2021, 58, 444-447
1.41Citations (PDF)
80Lung Function Trajectories: a New Framework to Understand Adult Chronic Respiratory Diseases
Barcelona Respiratory Network, 2021, 6,
0.00Citations (PDF)
81Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation
JAMA - Journal of the American Medical Association, 2021, 326, 1277
16.551Citations (PDF)
82Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD
Frontiers in Medicine, 2021, 8,
2.411Citations (PDF)
83Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
Lancet Respiratory Medicine,the, 2020, 8, 158-170
23.3112Citations (PDF)
84Clinical Fingerprinting: A Way to Address the Complexity and Heterogeneity of Bronchiectasis in Practice
American Journal of Respiratory and Critical Care Medicine, 2020, 201, 14-19
8.917Citations (PDF)
85An imported case of e-cigarette or vaping associated lung injury in Barcelona
European Respiratory Journal, 2020, 55, 1902076
8.726Citations (PDF)
86Chronic Obstructive Pulmonary Disease Pathogenesis
Clinics in Chest Medicine, 2020, 41, 307-314
3.410Citations (PDF)
87Phenotypic characterisation of early COPD: a prospective case–control study
ERJ Open Research, 2020, 6, 00047-2020
2.536Citations (PDF)
88Withdrawal of inhaled corticosteroids in COPD
European Respiratory Journal, 2020, 56, 2001684
8.71Citations (PDF)
89Amerindian Ancestry Influences Genetic Susceptibility to Chronic Obstructive Pulmonary Disease
Journal of Personalized Medicine, 2020, 10, 93
2.410Citations (PDF)
90Outcomes and cost of lung cancer patients treated surgically or medically in Catalunya: cost–benefit implications for lung cancer screening programs
European Journal of Cancer Prevention, 2020, 29, 486-492
2.010Citations (PDF)
91Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants
Radiology, 2020, 296, 208-215
8.710Citations (PDF)
92Blood eosinophil count in the general population: typical values and potential confounders
European Respiratory Journal, 2020, 55, 1901874
8.7160Citations (PDF)
93Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis
American Journal of Respiratory and Critical Care Medicine, 2020, 201, 1078-1085
8.9100Citations (PDF)
94Factors Associated with Low Lung Function in Different Age Bins in the General Population
American Journal of Respiratory and Critical Care Medicine, 2020, 202, 292-296
8.950Citations (PDF)
95Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
Respiratory Research, 2020, 21,
4.217Citations (PDF)
96Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
Chronic Respiratory Disease, 2019, 16,
1.720Citations (PDF)
97UPSTAGING, CENTRALITY AND SURVIVAL IN EARLY STAGE NON-SMALL CELL LUNG CANCER VIDEO-ASSISTED SURGERY
Lung Cancer, 2019, 134, 254-258
2.624Citations (PDF)
98Las bronquiectasias: una enfermedad compleja y heterogénea
Archivos De Bronconeumologia, 2019, 55, 427-433
1.418Citations (PDF)
99Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)
Respiratory Research, 2019, 20,
4.243Citations (PDF)
100Bronchiectasis: A Complex, Heterogeneous Disease
Archivos De Bronconeumologia, 2019, 55, 427-433
1.410Citations (PDF)
101EARLY COPD: determinantes de la aparición y progresión de la enfermedad pulmonar obstructiva crónica en adultos jóvenes. Protocolo de un estudio caso-control con seguimiento
Archivos De Bronconeumologia, 2019, 55, 312-318
1.411Citations (PDF)
102Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART
PLoS ONE, 2019, 14, e0224510
2.37Citations (PDF)
103Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease
New England Journal of Medicine, 2019, 381, 1248-1256
34.5499Citations (PDF)
104The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease
Archivos De Bronconeumologia, 2019, 55, 93-99
1.48Citations (PDF)
105Heterogeneidad y complejidad del síndrome bronquiectasias: un reto pendiente
Archivos De Bronconeumologia, 2019, 55, 187-188
1.412Citations (PDF)
106Prospective observational study in patients with obstructive lung disease: NOVELTY design
ERJ Open Research, 2019, 5, 00036-2018
2.547Citations (PDF)
107The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease
Clinical Cardiology, 2019, 42, 346-351
2.011Citations (PDF)
108Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case–Control Study With Follow-Up
Archivos De Bronconeumologia, 2019, 55, 312-318
1.46Citations (PDF)
109Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
BMC Pulmonary Medicine, 2019, 19,
2.453Citations (PDF)
110Benralizumab for the Prevention of COPD Exacerbations
New England Journal of Medicine, 2019, 381, 1023-1034
34.5325Citations (PDF)
111Precision medicine in obstructive sleep apnoea
Lancet Respiratory Medicine,the, 2019, 7, 456-464
23.3121Citations (PDF)
112Smoking Impairs the Immunomodulatory Capacity of Lung-Resident Mesenchymal Stem Cells in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory Cell and Molecular Biology, 2019, 61, 575-583
3.826Citations (PDF)
113Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
European Respiratory Journal, 2019, 53, 1802058
8.7290Citations (PDF)
114Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease
Medicine and Science in Sports and Exercise, 2019, 51, 833-840
0.849Citations (PDF)
115Heterogeneity and Complexity in Bronchiectasis: A Pending Challenge
Archivos De Bronconeumologia, 2019, 55, 187-188
1.42Citations (PDF)
116Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
European Respiratory Journal, 2019, 53, 1900164
8.71,631Citations (PDF)
117Lecciones de una vida: Conferencia Manuel Tapia 2018
Archivos De Bronconeumologia, 2019, 55, 177-180
1.40Citations (PDF)
118Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study
American Journal of Respiratory and Critical Care Medicine, 2019, 200, 454-461
8.9116Citations (PDF)
119Lung function trajectories in health and disease
Lancet Respiratory Medicine,the, 2019, 7, 358-364
23.3325Citations (PDF)
120Chronic obstructive pulmonary disease at the beginning of the XXI Century
Journal of Thoracic Disease, 2019, 11, E210-E213
1.21Citations (PDF)
121Early Life Origins of Asthma: A Review of Potential Effectors
Journal of Investigational Allergology and Clinical Immunology, 2019, 29, 168-179
1.536Citations (PDF)
122Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee
Annals of the American Thoracic Society, 2019, 16, 29-39
3.417Citations (PDF)
123Proyecto de biomarcadores y perfiles clínicos personalizados en la enfermedad pulmonar obstructiva crónica (proyecto BIOMEPOC)
Archivos De Bronconeumologia, 2019, 55, 93-99
1.425Citations (PDF)
124Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis
Respiratory Research, 2019, 20,
4.212Citations (PDF)
125The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study
Journal of Epidemiology, 2019, 29, 315-324
1.856Citations (PDF)
126From systems biology to P4 medicine: applications in respiratory medicine
European Respiratory Review, 2018, 27, 170110
8.242Citations (PDF)
127COPD: time to improve its taxonomy?
ERJ Open Research, 2018, 4, 00132-2017
2.5100Citations (PDF)
128Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype
European Respiratory Journal, 2018, 51, 1702146
8.781Citations (PDF)
129Hospitalizations due to exacerbations of COPD: A big data perspective
Respiratory Medicine, 2018, 145, 219-225
2.625Citations (PDF)
130Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD
European Respiratory Journal, 2018, 51, 1701457
8.772Citations (PDF)
131Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2018, 197, 400-403
8.910Citations (PDF)
132Spirometrically Confirmed Chronic Obstructive Pulmonary Disease Worsens Long-Term Prognosis after Percutaneous Coronary Intervention
American Journal of Respiratory and Critical Care Medicine, 2018, 197, 824-826
8.99Citations (PDF)
133After asthma: redefining airways diseases
Lancet, The, 2018, 391, 350-400
62.1966Citations (PDF)
134Pulmonary function predicts mortality and hospitalizations in outpatients with heart failure and preserved ejection fraction
Respiratory Medicine, 2018, 134, 124-129
2.615Citations (PDF)
135Expert Panel Discusses the Importance of Systems Medicine
Systems Medicine (New Rochelle, N Y ), 2018, 1, 3-8
0.71Citations (PDF)
136Inhaled corticosteroids in COPD: friend or foe?
European Respiratory Journal, 2018, 52, 1801219
8.7216Citations (PDF)
137Whole exome sequencing analysis in severe chronic obstructive pulmonary disease
Human Molecular Genetics, 2018, 27, 3801-3812
2.935Citations (PDF)
138Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
BMC Pulmonary Medicine, 2018, 18,
2.46Citations (PDF)
139The dyspnoea–inactivity vicious circle in COPD: development and external validation of a conceptual model
European Respiratory Journal, 2018, 52, 1800079
8.7144Citations (PDF)
140Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
ERJ Open Research, 2018, 4, 00022-2018
2.525Citations (PDF)
141How to Define Early Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2018, 198, 973-973
8.99Citations (PDF)
142Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?
American Journal of Respiratory and Critical Care Medicine, 2018, 198, 1000-1011
8.9182Citations (PDF)
143Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both
Respiratory Research, 2018, 19,
4.253Citations (PDF)
144Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort
Respiratory Medicine, 2018, 141, 14-19
2.615Citations (PDF)
145Current and Future Respiratory Medicine Challenges: Insights from a Barcelona Respiratory Network Foundation Retreat in Barcelona in 2017
Barcelona Respiratory Network, 2018, 4,
0.00Citations (PDF)
146Estudio de la validez de las versiones en catalán, gallego y vasco del cuestionario COPD assessment test y equivalencia con la versión en castellano
Archivos De Bronconeumologia, 2017, 53, 311-317
1.44Citations (PDF)
147Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Respirology, 2017, 22, 575-601
4.0323Citations (PDF)
148Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
European Respiratory Journal, 2017, 49, 1700214
8.7616Citations (PDF)
149Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine, 2017, 195, 557-582
8.92,798Citations (PDF)
150Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Archivos De Bronconeumologia, 2017, 53, 128-149
1.4188Citations (PDF)
151Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
Thorax, 2017, 72, 117-121
5.661Citations (PDF)
152Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects
American Journal of Respiratory Cell and Molecular Biology, 2017, 57, 35-46
3.865Citations (PDF)
153The microbiome in respiratory medicine: current challenges and future perspectives
European Respiratory Journal, 2017, 49, 1602086
8.7230Citations (PDF)
154The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 2017, 72, 1492-1500
3.467Citations (PDF)
155Validity Study of Catalan, Galician and Basque Language Versions of the COPD Assessment Test and Equivalence With the Spanish Version
Archivos De Bronconeumologia, 2017, 53, 311-317
1.41Citations (PDF)
156Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
Thorax, 2017, 72, 998-1006
5.688Citations (PDF)
157Predicting the future from the past: volatile markers for respiratory infections
European Respiratory Journal, 2017, 49, 1750264
8.71Citations (PDF)
158Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
Archivos De Bronconeumologia, 2017, 53, 128-149
1.4336Citations (PDF)
159Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1
Journal of Cachexia, Sarcopenia and Muscle, 2017, 8, 428-436
9.114Citations (PDF)
160Multi-level differential network analysis of COPD exacerbations
European Respiratory Journal, 2017, 50, 1700075
8.743Citations (PDF)
161Precision medicine in airway diseases: moving to clinical practice
European Respiratory Journal, 2017, 50, 1701655
8.7200Citations (PDF)
162What does endotyping mean for treatment in chronic obstructive pulmonary disease?
Lancet, The, 2017, 390, 980-987
62.190Citations (PDF)
163Blood eosinophil count and exacerbation risk in patients with COPD
European Respiratory Journal, 2017, 50, 1700761
8.775Citations (PDF)
164Towards a global initiative for fibrosis treatment (GIFT)
ERJ Open Research, 2017, 3, 00106-2017
2.58Citations (PDF)
165Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, 2017, 18, 1097.e11-1097.e24
2.445Citations (PDF)
166Lung function in early adulthood and health in later life: a transgenerational cohort analysis
Lancet Respiratory Medicine,the, 2017, 5, 935-945
23.3328Citations (PDF)
167Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women
American Journal of Respiratory Cell and Molecular Biology, 2017, 56, 332-341
3.831Citations (PDF)
168Natural history of COPD: gaps and opportunities
ERJ Open Research, 2017, 3, 00117-2017
2.548Citations (PDF)
169The EASI model: A first integrative computational approximation to the natural history of COPD
PLoS ONE, 2017, 12, e0185502
2.34Citations (PDF)
170Inspiratory capacity‐to‐total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD
Respirology, 2016, 21, 476-482
4.020Citations (PDF)
171Multilevel, Dynamic Chronic Obstructive Pulmonary Disease Heterogeneity. A Challenge for Personalized Medicine
Annals of the American Thoracic Society, 2016, 13, S466-S470
3.424Citations (PDF)
172Ausencia de correlación entre marcadores de inflamación pulmonar y sistémica en pacientes con enfermedad pulmonar obstructiva crónica: un análisis bi-compartimental simultáneo
Archivos De Bronconeumologia, 2016, 52, 361-367
1.417Citations (PDF)
173Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD
Chest, 2016, 150, 123-130
1.056Citations (PDF)
174Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2016, 13, 669-676
2.09Citations (PDF)
175The inflammasome pathway in stable COPD and acute exacerbations
ERJ Open Research, 2016, 2, 00002-2016
2.564Citations (PDF)
176Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
American Journal of Respiratory and Critical Care Medicine, 2016, 194, 1319-1336
8.9217Citations (PDF)
177Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study
Respiratory Medicine, 2016, 119, 87-95
2.634Citations (PDF)
178Biomarkers, the control panel and personalized COPD medicine
Respirology, 2016, 21, 24-33
4.044Citations (PDF)
179Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2016, 194, 541-549
8.977Citations (PDF)
180Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis
Archivos De Bronconeumologia, 2016, 52, 361-367
1.414Citations (PDF)
181Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2016, 194, 48-57
8.955Citations (PDF)
182A comparison of COPD patients with and without ACOS in the ECLIPSE study
European Respiratory Journal, 2016, 47, 1559-1562
8.742Citations (PDF)
183Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial
Contemporary Clinical Trials Communications, 2016, 2, 91-96
1.216Citations (PDF)
184Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
European Respiratory Journal, 2016, 47, 1365-1373
8.777Citations (PDF)
185Treatable traits: toward precision medicine of chronic airway diseases
European Respiratory Journal, 2016, 47, 410-419
8.7969Citations (PDF)
186Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema
American Journal of Respiratory and Critical Care Medicine, 2016, 193, 1242-1253
8.9133Citations (PDF)
187Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
American Journal of Respiratory and Critical Care Medicine, 2016, 193, 427-437
8.9171Citations (PDF)
188Relevance of Systems Biology to Respiratory Medicine
Barcelona Respiratory Network, 2016, 2,
0.00Citations (PDF)
189Relevance of Systems Biology to Respiratory Medicine
Barcelona Respiratory Network, 2016, 2,
0.00Citations (PDF)
190Determinants of between‐hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit ( AUDIPOC ) in Spain
International Journal of Clinical Practice, 2015, 69, 938-947
3.026Citations (PDF)
191Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD
BMC Pulmonary Medicine, 2015, 15,
2.422Citations (PDF)
192Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations
PLoS ONE, 2015, 10, e0135199
2.375Citations (PDF)
193Ventilation/Perfusion Distribution Abnormalities In Morbidly Obese Subjects Before and After Bariatric Surgery
Chest, 2015, 147, 1127-1134
1.059Citations (PDF)
194Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2015, 192, 523-525
8.9391Citations (PDF)
195B Cell–Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2015, 192, 695-705
8.9113Citations (PDF)
196Chronic obstructive pulmonary disease: The golden decade. Implications for the diagnosis, prevention and treatment of chronic obstructive pulmonary disease
Medicina Clínica (English Edition), 2015, 144, 507-513
0.11Citations (PDF)
197Personalized Respiratory Medicine: Exploring the Horizon, Addressing the Issues. Summary of a BRN-AJRCCM Workshop Held in Barcelona on June 12, 2014
American Journal of Respiratory and Critical Care Medicine, 2015, 191, 391-401
8.965Citations (PDF)
198Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis
Annals of the American Thoracic Society, 2015, 12, 303-312
3.4142Citations (PDF)
199Benefits of physical activity on COPD hospitalisation depend on intensity
European Respiratory Journal, 2015, 46, 1281-1289
8.783Citations (PDF)
200Molecular and clinical diseasome of comorbidities in exacerbated COPD patients
European Respiratory Journal, 2015, 46, 1001-1010
8.736Citations (PDF)
201The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?
Lancet Respiratory Medicine,the, 2015, 3, 719-728
23.3157Citations (PDF)
202Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung
American Journal of Respiratory and Critical Care Medicine, 2015, 192, 785-792
8.996Citations (PDF)
203Clinical and prognostic heterogeneity of C and D GOLD groups
European Respiratory Journal, 2015, 46, 250-254
8.711Citations (PDF)
204Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
New England Journal of Medicine, 2015, 373, 111-122
34.51,214Citations (PDF)
205Assessment of health status and program performance in patients on long-term oxygen therapy
Respiratory Medicine, 2015, 109, 500-509
2.623Citations (PDF)
206Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
Lancet, The, 2015, 385, 1789-1798
62.1230Citations (PDF)
207Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation
BMC Pulmonary Medicine, 2015, 15,
2.423Citations (PDF)
208One-year change in health status and subsequent outcomes in COPD
Thorax, 2015, 70, 420-425
5.652Citations (PDF)
209Hospitalized Exacerbations of COPD
Chest, 2015, 147, 999-1007
1.0306Citations (PDF)
210Salmeterol/fluticasone combination instead of indacaterol orvice-versa?
European Respiratory Journal, 2015, 45, 1187-1188
8.71Citations (PDF)
211An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
European Respiratory Journal, 2015, 45, 879-905
8.7146Citations (PDF)
212Lung-Function Trajectories and Chronic Obstructive Pulmonary Disease
New England Journal of Medicine, 2015, 373, 1574-1575
34.525Citations (PDF)
213Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer
Cancer Immunology, Immunotherapy, 2015, 64, 1261-1270
4.635Citations (PDF)
214Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study
Respiratory Medicine, 2015, 109, 1138-1146
2.699Citations (PDF)
215Continuous fat-free mass decline in COPD: fact or fiction?
European Respiratory Journal, 2015, 46, 1496-1498
8.714Citations (PDF)
216Enfermedad pulmonar obstructiva crónica: la década prodigiosa. Implicaciones para su diagnóstico, prevención y tratamiento
Medicina Clínica, 2015, 144, 507-513
0.84Citations (PDF)
217The Natural History of COPD: Beyond Fletcher and Peto
Barcelona Respiratory Network, 2015, 1,
0.01Citations (PDF)
218The Natural History of COPD: Beyond Fletcher and Peto
Barcelona Respiratory Network, 2015, 1,
0.00Citations (PDF)
219Critical assessment of the current guidelines for the management and treatment of morbidly obese patients
Journal of Endocrinological Investigation, 2014, 30, 844-852
2.830Citations (PDF)
220Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
PLoS ONE, 2014, 9, e97491
2.345Citations (PDF)
221The Systemic Inflammome of Severe Obesity before and after Bariatric Surgery
PLoS ONE, 2014, 9, e107859
2.351Citations (PDF)
222Fibrinogen and COPD: Now what?
Chronic Obstructive Pulmonary Diseases (Miami, Fla ), 2014, 2, 1-3
0.817Citations (PDF)
223Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns
Chronic Obstructive Pulmonary Diseases (Miami, Fla ), 2014, 1, 166-184
0.826Citations (PDF)
224A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease
BMC Systems Biology, 2014, 8,
3.124Citations (PDF)
225Network Analysis in the Investigation of Chronic Respiratory Diseases. From Basics to Application
American Journal of Respiratory and Critical Care Medicine, 2014, 190, 981-988
8.945Citations (PDF)
226Eosinophilic inflammation in COPD: prevalence and clinical characteristics
European Respiratory Journal, 2014, 44, 1697-1700
8.7464Citations (PDF)
227Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients
European Respiratory Journal, 2014, 44, 603-613
8.7109Citations (PDF)
228Inhaled corticosteroids and systemic inflammatory response in community‐acquired pneumonia: A prospective clinical study
Respirology, 2014, 19, 929-935
4.020Citations (PDF)
229Prevalence of and risk factors for pulmonary abnormalities in HIV‐infected patients treated with antiretroviral therapy
HIV Medicine, 2014, 15, 321-329
2.868Citations (PDF)
230Common Genetic Variants Associated with Resting Oxygenation in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory Cell and Molecular Biology, 2014, 51, 678-687
3.819Citations (PDF)
231Network medicine analysis of COPD multimorbidities
Respiratory Research, 2014, 15,
4.251Citations (PDF)
232Biomarkers in COPD
Clinics in Chest Medicine, 2014, 35, 131-141
3.453Citations (PDF)
233Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality
Thorax, 2014, 69, 718-723
5.6192Citations (PDF)
234Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
Thorax, 2014, 69, 72-79
5.668Citations (PDF)
235Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Respiratory Medicine, 2014, 108, 1647-1654
2.626Citations (PDF)
236Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease
Respiratory Medicine, 2014, 108, 1608-1614
2.662Citations (PDF)
237A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
European Respiratory Journal, 2014, 43, 763-772
8.754Citations (PDF)
238Characterisation and impact of reported and unreported exacerbations: results from ATTAIN
European Respiratory Journal, 2014, 44, 1156-1165
8.774Citations (PDF)
239Structure–function relationship in COPD revisited: an in vivo microscopy view
Thorax, 2014, 69, 724-730
5.610Citations (PDF)
240The path to personalised medicine in COPD
Thorax, 2014, 69, 857-864
5.6174Citations (PDF)
241Lung Function Abnormalities are Highly Frequent in Patients with Heart Failure and Preserved Ejection Fraction
Heart Lung and Circulation, 2014, 23, 273-279
0.944Citations (PDF)
242Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study
Annals of the American Thoracic Society, 2014, 11, 326-334
3.4228Citations (PDF)
243Lessons from ECLIPSE: a review of COPD biomarkers
Thorax, 2014, 69, 666-672
5.6140Citations (PDF)
244Hospital admissions and exercise capacity decline in patients with COPD
European Respiratory Journal, 2014, 43, 1018-1027
8.741Citations (PDF)
245Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations
Respiratory Medicine, 2014, 108, 1153-1162
2.6105Citations (PDF)
246Should We View Chronic Obstructive Pulmonary Disease Differently after ECLIPSE?. A Clinical Perspective from the Study Team
American Journal of Respiratory and Critical Care Medicine, 2014, 189, 1022-1030
8.9140Citations (PDF)
247Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management
Journal of Translational Medicine, 2014, 12, S3
6.437Citations (PDF)
248Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns
Chronic Obstructive Pulmonary Diseases (Miami, Fla ), 2014, 1, 166-184
0.80Citations (PDF)
249A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD
Respiratory Medicine, 2013, 107, 560-569
2.689Citations (PDF)
250Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2013, 188, 948-957
8.9151Citations (PDF)
251Cardiovascular Comorbidity in COPD
Chest, 2013, 144, 1163-1178
1.0331Citations (PDF)
252Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
Respiratory Medicine, 2013, 107, 1376-1384
2.6397Citations (PDF)
253Pathophysiology of muscle dysfunction in COPD
Journal of Applied Physiology, 2013, 114, 1222-1234
2.8200Citations (PDF)
254Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2013, 187, 347-365
8.97,110Citations (PDF)
255Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach
Respiratory Medicine, 2013, 107, 1817-1821
2.691Citations (PDF)
256Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells
Respiratory Medicine, 2013, 107, 1895-1903
2.631Citations (PDF)
257The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study
Lancet Respiratory Medicine,the, 2013, 1, 129-136
23.3255Citations (PDF)
258Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2013, 187, 382-386
8.9308Citations (PDF)
259FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
European Respiratory Journal, 2013, 42, 1391-1401
8.790Citations (PDF)
260Lungs, Bone Marrow, and Adipose Tissue. A Network Approach to the Pathobiology of Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2013, 188, 1396-1406
8.934Citations (PDF)
261The COPD control panel: towards personalised medicine in COPD
Thorax, 2013, 68, 687-690
5.6107Citations (PDF)
262Authors response. The chronic obstructive pulmonary disease (COPD) control panel: towards personalised medicine in COPD
Thorax, 2013, 68, 389-390
5.60Citations (PDF)
263Phenotypes and Disease Characterization in Chronic Obstructive Pulmonary Disease. Toward the Extinction of Phenotypes?
Annals of the American Thoracic Society, 2013, 10, S125-S130
3.444Citations (PDF)
264HLA Distribution in COPD Patients
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2013, 10, 138-146
2.018Citations (PDF)
265Immune response in chronic obstructive pulmonary disease
Expert Review of Clinical Immunology, 2013, 9, 821-833
3.542Citations (PDF)
266Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
European Respiratory Journal, 2013, 42, 636-646
8.7173Citations (PDF)
267Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis
Journal of Thoracic Oncology, 2013, 8, e34
2.13Citations (PDF)
268Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea
European Respiratory Journal, 2012, 39, 913-918
8.720Citations (PDF)
269Update in Chronic Obstructive Pulmonary Disease 2011
American Journal of Respiratory and Critical Care Medicine, 2012, 185, 1171-1176
8.925Citations (PDF)
270Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine, 2012, 186, 306-313
8.9242Citations (PDF)
271Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
European Respiratory Journal, 2012, 40, 830-836
8.7174Citations (PDF)
272Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension
JAMA - Journal of the American Medical Association, 2012, 307,
16.5675Citations (PDF)
273Systemic Steroid Exposure Is Associated with Differential Methylation in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2012, 186, 1248-1255
8.976Citations (PDF)
274Monitoring Breathing Rate at Home Allows Early Identification of COPD Exacerbations
Chest, 2012, 142, 1524-1529
1.0109Citations (PDF)
275Chronic Obstructive Pulmonary Disease Phenotypes: Current Rather than Future Perspectives: Reply
American Journal of Respiratory and Critical Care Medicine, 2012, 185, 590-590
8.91Citations (PDF)
276Genome-Wide Association Analysis of Blood Biomarkers in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2012, 186, 1238-1247
8.9124Citations (PDF)
277Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
Thorax, 2012, 67, 701-708
5.6176Citations (PDF)
278The GOLD Initiative 2011: A Change of Paradigm?
Archivos De Bronconeumologia, 2012, 48, 286-289
1.49Citations (PDF)
279Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, 2012, 13, 291-297
2.4218Citations (PDF)
280Effect of Bronchial Colonisation on Airway and Systemic Inflammation in Stable COPD
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2012, 9, 121-130
2.062Citations (PDF)
281Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2012, 185, 1065-1072
8.9402Citations (PDF)
282Iniciativa GOLD 2011. ¿Cambio de paradigma?
Archivos De Bronconeumologia, 2012, 48, 286-289
1.417Citations (PDF)
283A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13
Human Molecular Genetics, 2012, 21, 947-957
2.9228Citations (PDF)
284An investigation of the resolution of inflammation (catabasis) in COPD
Respiratory Research, 2012, 13,
4.222Citations (PDF)
285Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations?
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2012, 9, 492-498
2.077Citations (PDF)
286Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome
Human Molecular Genetics, 2012, 21, 3073-3082
2.9292Citations (PDF)
287Site of Mitochondrial Reactive Oxygen Species Production in Skeletal Muscle of Chronic Obstructive Pulmonary Disease and Its Relationship with Exercise Oxidative Stress
American Journal of Respiratory Cell and Molecular Biology, 2012, 47, 358-362
3.850Citations (PDF)
288Variable DNA Methylation Is Associated with Chronic Obstructive Pulmonary Disease and Lung Function
American Journal of Respiratory and Critical Care Medicine, 2012, 185, 373-381
8.9218Citations (PDF)
289Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
PLoS ONE, 2012, 7, e37483
2.3747Citations (PDF)
290Clinical Audit of COPD Patients Requiring Hospital Admissions in Spain: AUDIPOC Study
PLoS ONE, 2012, 7, e42156
2.3102Citations (PDF)
291Systems medicine and integrated care to combat chronic noncommunicable diseases
Genome Medicine, 2011, 3, 43
9.6187Citations (PDF)
292Current Controversies and Future Perspectives in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2011, 184, 507-513
8.9102Citations (PDF)
293PR1 Responsiveness of the Copd Assessment Test (CAT) Questionnaire During Exacerbations of COPD
Value in Health, 2011, 14, A541
1.90Citations (PDF)
294P4 Medicine: the Future Around the Corner
Archivos De Bronconeumologia, 2011, 47, 35-40
1.437Citations (PDF)
295Molecular Mechanisms of Inflammation During Exacerbations of Chronic Obstructive Pulmonary Disease
Archivos De Bronconeumologia, 2011, 47, 176-183
1.434Citations (PDF)
296Medicina P4: el futuro a la vuelta de la esquina
Archivos De Bronconeumologia, 2011, 47, 35-40
1.452Citations (PDF)
297Mecanismos moleculares de inflamación durante las agudizaciones de la enfermedad pulmonar obstructiva crónica
Archivos De Bronconeumologia, 2011, 47, 176-183
1.462Citations (PDF)
298Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
Respiratory Research, 2011, 12,
4.276Citations (PDF)
299Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2011, 183, 1025-1031
8.9102Citations (PDF)
300Is Autoimmunity Really Related to the Pathogenesis of COPD?
American Journal of Respiratory and Critical Care Medicine, 2011, 184, 1213-1213
8.912Citations (PDF)
301Night-time symptoms: a forgotten dimension of COPD
European Respiratory Review, 2011, 20, 183-194
8.2220Citations (PDF)
302The CIBERES Pulmonary Biobank Consortium: an opportunity for cooperative international respiratory research
European Respiratory Journal, 2011, 37, 204-206
8.710Citations (PDF)
303Candidate genes for COPD in two large data sets
European Respiratory Journal, 2011, 37, 255-263
8.745Citations (PDF)
304Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
Thorax, 2011, 66, 430-437
5.6283Citations (PDF)
305Changes in Forced Expiratory Volume in 1 Second over Time in COPD
New England Journal of Medicine, 2011, 365, 1184-1192
34.5897Citations (PDF)
306Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD
Thorax, 2011, 66, 121-127
5.663Citations (PDF)
307The influence of obesity and obstructive sleep apnea on metabolic hormones
Sleep and Breathing, 2011, 16, 649-656
1.561Citations (PDF)
308Impaired circadian variation of platelet activity in patients with sleep apnea
Sleep and Breathing, 2011, 16, 355-360
1.526Citations (PDF)
309α;1-Antitrypsin Protease Inhibitor MZ Heterozygosity Is Associated With Airflow Obstruction in Two Large Cohorts
Chest, 2010, 138, 1125-1132
1.081Citations (PDF)
310Abnormal Levels of Circulating Endothelial Progenitor Cells During Exacerbations of COPD
Lung, 2010, 188, 331-338
2.642Citations (PDF)
311Impacto de las nuevas opciones terapéuticas en la EPOC
Archivos De Bronconeumologia, 2010, 46, 1-2
1.40Citations (PDF)
312Introducción
Archivos De Bronconeumologia, 2010, 46, 1
1.40Citations (PDF)
313Fenotipos clínicos de la EPOC
Archivos De Bronconeumologia, 2010, 46, 8-11
1.414Citations (PDF)
314Characterisation of COPD heterogeneity in the ECLIPSE cohort
Respiratory Research, 2010, 11,
4.21,040Citations (PDF)
315Auditoria clínica de los pacientes hospitalizados por exacerbación de EPOC en España (estudio AUDIPOC): método y organización del trabajo
Archivos De Bronconeumologia, 2010, 46, 349-357
1.431Citations (PDF)
316Variability and effects of bronchial colonisation in patients with moderate COPD
European Respiratory Journal, 2010, 35, 295-302
8.783Citations (PDF)
317High Prevalence of Undiagnosed Airflow Limitation in Patients With Cardiovascular Disease
Chest, 2010, 137, 333-340
1.088Citations (PDF)
318Multistudy Fine Mapping of Chromosome 2q Identifies XRCC5 as a Chronic Obstructive Pulmonary Disease Susceptibility Gene
American Journal of Respiratory and Critical Care Medicine, 2010, 182, 605-613
8.929Citations (PDF)
319Clinical Audit of Patients Admitted to Hospital in Spain due to Exacerbation of COPD (AUDIPOC Study): Method and Organisation
Archivos De Bronconeumologia, 2010, 46, 349-357
1.423Citations (PDF)
320Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
New England Journal of Medicine, 2010, 363, 1128-1138
34.52,666Citations (PDF)
321Prognosis of COPD patients requiring frequent hospitalization: Role of airway infection
Respiratory Medicine, 2010, 104, 840-848
2.633Citations (PDF)
322Telomere shortening in sleep apnea syndrome
Respiratory Medicine, 2010, 104, 1225-1229
2.672Citations (PDF)
323Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea
Sleep and Breathing, 2010, 15, 403-408
1.54Citations (PDF)
324NontypeableHaemophilus influenzaeClearance by Alveolar Macrophages Is Impaired by Exposure to Cigarette Smoke
Infection and Immunity, 2009, 77, 4232-4242
2.7123Citations (PDF)
325Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD
Thorax, 2009, 64, 424-429
5.6142Citations (PDF)
326The Natural History of Chronic Airflow Obstruction Revisited
American Journal of Respiratory and Critical Care Medicine, 2009, 180, 3-10
8.9607Citations (PDF)
327Abnormal Transition Pore Kinetics and Cytochrome C Release in Muscle Mitochondria of Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory Cell and Molecular Biology, 2009, 40, 746-750
3.844Citations (PDF)
328Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients
European Respiratory Journal, 2009, 33, 1045-1052
8.7165Citations (PDF)
329A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations
Journal of Critical Care, 2009, 24, 473.e7-473.e14
2.350Citations (PDF)
330Actividad de una unidad de cuidados respiratorios intermedios dependiente de un servicio de neumología
Archivos De Bronconeumologia, 2009, 45, 168-172
1.415Citations (PDF)
331La heterogeneidad fenotípica de la EPOC
Archivos De Bronconeumologia, 2009, 45, 129-138
1.428Citations (PDF)
332EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad
Archivos De Bronconeumologia, 2009, 45, 14-17
1.46Citations (PDF)
333CTLA4gene polymorphisms are associated with chronic bronchitis
European Respiratory Journal, 2009, 34, 598-604
8.729Citations (PDF)
334Prediction of risk of COPD exacerbations by the BODE index
Respiratory Medicine, 2009, 103, 373-378
2.6134Citations (PDF)
335Characteristics of patients admitted for the first time for COPD exacerbation
Respiratory Medicine, 2009, 103, 1293-1302
2.657Citations (PDF)
336Immunologic Aspects of Chronic Obstructive Pulmonary Disease
New England Journal of Medicine, 2009, 360, 2445-2454
34.5742Citations (PDF)
337Activity of an Intermediate Respiratory Care Unit Attached to a Respiratory Medicine Department
Archivos De Bronconeumologia, 2009, 45, 168-172
1.46Citations (PDF)
338Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial
Thorax, 2009, 64, 581-586
5.6170Citations (PDF)
339Physical Activity and Clinical and Functional Status in COPD
Chest, 2009, 136, 62-70
1.0151Citations (PDF)
340Investigating the Natural History of Lung Function
Chest, 2009, 135, 1330-1341
1.033Citations (PDF)
341Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease
Journal of Clinical Investigation, 2009, 119, 636-649
10.668Citations (PDF)
342Impacto de la presencia de un neumólogo de guardia sobre la actividad de un servicio de neumología
Archivos De Bronconeumologia, 2008, 44, 484-488
1.43Citations (PDF)
343Impact of an On-duty Pulmonologist on the Activity of a Respiratory Medicine Department
Archivos De Bronconeumologia, 2008, 44, 484-488
1.41Citations (PDF)
344CIBER of Respiratory Diseases (CibeRes)
Archivos De Bronconeumologia, 2008, 44, 489-492
1.47Citations (PDF)
345COPD as a Systemic Disease
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2008, 5, 133-138
2.0232Citations (PDF)
346Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking
European Respiratory Journal, 2008, 31, 555-562
8.7184Citations (PDF)
347Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2008, 178, 500-505
8.9285Citations (PDF)
348Fluticasone propionate reduces bacterial airway epithelial invasion
European Respiratory Journal, 2008, 32, 1283-1288
8.729Citations (PDF)
349Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers
European Respiratory Journal, 2008, 33, 273-281
8.747Citations (PDF)
350Insulin resistance and daytime sleepiness in patients with sleep apnoea
Thorax, 2008, 63, 946-950
5.6154Citations (PDF)
351Impacto de la presencia de un neumólogo de guardia sobre la actividad de un servicio de neumología
Archivos De Bronconeumologia, 2008, 44, 484-488
1.40Citations (PDF)
352El CIBER de Enfermedades Respiratorias (CibeRes)
Archivos De Bronconeumologia, 2008, 44, 489-492
1.40Citations (PDF)
353Hipersonolência diurna e variáveis polissonográficas em doentes com síndroma de apneia do sono
Revista Portuguesa De Pneumologia, 2007, 13, 896-898
1.113Citations (PDF)
354β3-Adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea
European Respiratory Journal, 2007, 30, 743-747
8.719Citations (PDF)
355Daytime sleepiness and polysomnographic variables in sleep apnoea patients
European Respiratory Journal, 2007, 30, 110-113
8.7206Citations (PDF)
356Prostaglandin D synthase (β trace) levels in sleep apnea patients with and without sleepiness
Sleep Medicine, 2007, 8, 509-511
1.639Citations (PDF)
357Hipersonolência diurna e variáveis polissonográficas em doentes com síndroma de apneia do sono
Revista Portuguesa De Pneumologia, 2007, 13, 896-898
1.16Citations (PDF)
358Reduced Expression of the Sarcoplasmic Calcium Pump SERCA2 in Skeletal Muscle From Patients With Chronic Obstructive Pulmonary Disease and Low Body Weight
Archivos De Bronconeumologia, 2007, 43, 4-8
1.411Citations (PDF)
359Disminución de la expresión de la bomba de calcio sarcoplásmica (SERCA2) en el músculo esquelético de pacientes con EPOC y bajo peso corporal
Archivos De Bronconeumologia, 2007, 43, 4-8
1.45Citations (PDF)
360Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness
Sleep and Breathing, 2007, 11, 177-185
1.593Citations (PDF)
361Mortality in COPD: role of comorbidities
European Respiratory Journal, 2006, 28, 1245-1257
8.7960Citations (PDF)
362Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease
Respiratory Research, 2006, 7,
4.274Citations (PDF)
363Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease
Clinical and Experimental Immunology, 2006, 145, 474-479
3.3106Citations (PDF)
364Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?: FIGURE 1.
European Respiratory Review, 2006, 15, 68-71
8.217Citations (PDF)
365Telomere shortening in smokers with and without COPD
European Respiratory Journal, 2006, 27, 525-528
8.7297Citations (PDF)
366Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment
European Respiratory Journal, 2006, 27, 756-760
8.7196Citations (PDF)
367The potential impact of anaemia of chronic disease in COPD
European Respiratory Journal, 2006, 27, 390-396
8.7153Citations (PDF)
368Outcomes and markers in the assessment of chronic obstructive pulmonary disease
European Respiratory Journal, 2006, 27, 822-832
8.7222Citations (PDF)
369Autoinmunidad en la EPOC
Archivos De Bronconeumologia, 2005, 41, 10-14
1.45Citations (PDF)
370Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidencia
Archivos De Bronconeumologia, 2005, 41, 220-229
1.414Citations (PDF)
371Blunted    T-lymphocyte response in chronic obstructive pulmonary disease
European Respiratory Journal, 2005, 25, 441-446
8.747Citations (PDF)
372Neuropeptide Y and Leptin in Patients with Obstructive Sleep Apnea Syndrome
American Journal of Respiratory and Critical Care Medicine, 2005, 171, 183-187
8.9128Citations (PDF)
373Systemic Effects of Chronic Obstructive Pulmonary Disease
Proceedings of the American Thoracic Society, 2005, 2, 367-370
0.0250Citations (PDF)
374Decreased macrophage release of TGF-  and TIMP-1 in chronic obstructive pulmonary disease
European Respiratory Journal, 2005, 26, 60-66
8.757Citations (PDF)
375Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD
European Respiratory Journal, 2005, 25, 647-652
8.791Citations (PDF)
376Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
Lancet, The, 2005, 365, 1046-1053
62.14,352Citations (PDF)
377Empleo de esteroides inhalados en el tratamiento de la EPOC
Revista Clinica Espanola, 2005, 205, 24-26
0.10Citations (PDF)
378COPD, a multicomponent disease: implications for management
Respiratory Medicine, 2005, 99, 670-682
2.6180Citations (PDF)
379Proposal for a multidimensional staging system for chronic obstructive pulmonary disease
Respiratory Medicine, 2005, 99, 1546-1554
2.659Citations (PDF)
380Read Me, Please!
Archivos De Bronconeumologia, 2005, 41, 50-52
1.43Citations (PDF)
381Hospital Treatment of Chronic Obstructive Pulmonary Disease Exacerbations: an Evidence-Based Review
Archivos De Bronconeumologia, 2005, 41, 220-229
1.45Citations (PDF)
382Effects of obesity upon genioglossus structure and function in obstructive sleep apnoea
European Respiratory Journal, 2004, 23, 425-429
8.787Citations (PDF)
383COPD at the 2004 9th European Pulmonary Summit
Pulmonary Pharmacology and Therapeutics, 2004, 17, 249-251
2.32Citations (PDF)
384Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea
American Journal of Medicine, 2004, 117, 118-121
2.0124Citations (PDF)
385Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
European Respiratory Journal, 2004, 23, 932-946
8.73,959Citations (PDF)
386Expression of Adhesion Molecules During Apoptosis of Circulating Neutrophils in COPD
Chest, 2004, 125, 1837-1842
1.042Citations (PDF)
387EPOC, ¿adónde vamos?
Archivos De Bronconeumologia, 2004, 40, 6-8
1.44Citations (PDF)
388Nitric oxide synthase type I (nNOS), vascular endothelial growth factor (VEGF) and myoglobin-like expression in skeletal muscle of Antarctic icefishes (Notothenioidei: Channichthyidae)
Polar Biology, 2003, 26, 458-462
1.216Citations (PDF)
389Long-term (72 hours) preservation of rat lungs
Journal of Thoracic and Cardiovascular Surgery, 2003, 125, 907-912
2.64Citations (PDF)
390El ruido monótono no afecta a las capacidades cognitivas en pacientes con síndrome de apnea del sueño
Archivos De Bronconeumologia, 2003, 39, 405-408
1.44Citations (PDF)
391Differential Response of Lymphocytes and Neutrophils to High Intensity Physical Activity and to Vitamin C Diet Supplementation
Free Radical Research, 2003, 37, 931-938
2.646Citations (PDF)
392Skeletal muscle changes in patients with obstructive sleep apnoea syndrome
Respiratory Medicine, 2003, 97, 804-810
2.653Citations (PDF)
393Systemic effects of chronic obstructive pulmonary disease
European Respiratory Journal, 2003, 21, 347-360
8.7796Citations (PDF)
394Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 2002, 166, 485-489
8.9315Citations (PDF)
395Plasminogen activator inhibitor-1 (PAI-1) polymorphisms in patients with obstructive sleep apnoea
Respiratory Medicine, 2002, 96, 193-196
2.614Citations (PDF)
396Recuperación de la función pulmonar tras colecistectomía laparoscópica: papel del dolor postoperatorio
Archivos De Bronconeumologia, 2002, 38, 72-76
1.46Citations (PDF)
397Todo por la audiencia. Algunas recomendaciones para una presentación en público eficaz
Archivos De Bronconeumologia, 2002, 38, 49-50
1.42Citations (PDF)
398Inflamación sistémica durante las agudizaciones de la enfermedad pulmonar obstructiva crónica
Archivos De Bronconeumologia, 2002, 38, 172-176
1.442Citations (PDF)
399Continuous Positive Airway Pressure in Patients without Daytime Sleepiness
Annals of Internal Medicine, 2002, 137, 370
9.60Citations (PDF)
400Disfunción muscular esquelética de la EPOC. Mecanismos celulares
Archivos De Bronconeumologia, 2001, 37, 197-205
1.410Citations (PDF)
401Análisis de la repercusión de Archivos De Bronconeumología a través del Science Citation Index
Archivos De Bronconeumologia, 2001, 37, 465-470
1.423Citations (PDF)
402Tratamiento de la enfermedad pulmonar obstructiva crónica
Revista Clinica Espanola, 2001, 201, 417-423
0.19Citations (PDF)
403Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica
Archivos De Bronconeumologia, 2001, 37, 297-316
1.4193Citations (PDF)
404Chip genético (ADN array): el futuro ya está aquí
Archivos De Bronconeumologia, 2001, 37, 394-396
1.45Citations (PDF)
405Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD
European Respiratory Journal, 2001, 17, 1138-1142
8.756Citations (PDF)
406Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms
European Respiratory Journal, 2001, 17, 728-732
8.786Citations (PDF)
407Enhanced neutrophil response in chronic obstructive pulmonary disease
Thorax, 2001, 56, 432-437
5.6198Citations (PDF)
408From the Authors
European Respiratory Journal, 2001, 18, 1078-1078
8.70Citations (PDF)
409Enhanced neutrophil response in chronic obstructive pulmonary disease
Thorax, 2001, 56, 432-437
5.652Citations (PDF)
410The measurement of exhaled carbon monoxide is influenced by airflow obstruction
European Respiratory Journal, 2000, 15, 177-180
8.731Citations (PDF)
411Papel de la vía aérea superior en la patogenia del síndrome de apneas obstructivas del sueño
Archivos De Bronconeumologia, 2000, 36, 574-579
1.42Citations (PDF)
412Changes induced by oxygen in rat liver proteins identified by high-resolution two-dimensional gel electrophoresis
FEBS Journal, 2000, 267, 5580-5584
0.26Citations (PDF)
413Abnormal lipid peroxidation in patients with sleep apnoea
European Respiratory Journal, 2000, 16, 644
8.7233Citations (PDF)
414The Activity of Cytochrome Oxidase Is Increased in Circulating Lymphocytes of Patients with Chronic Obstructive Pulmonary Disease, Asthma, and Chronic Arthritis
American Journal of Respiratory and Critical Care Medicine, 2000, 161, 32-35
8.9113Citations (PDF)
415Regulation of iNOS expression and glutathione levels in rat liver by oxygen tension
FEBS Letters, 2000, 476, 253-257
2.731Citations (PDF)
416The measurement of exhaled carbon monoxide is influenced by airflow obstruction
European Respiratory Journal, 2000, 15, 177
8.71Citations (PDF)
417Lack of effects of moderate-high altitude upon lung function in healthy middle-aged volunteers
Respiratory Medicine, 1999, 93, 739-743
2.69Citations (PDF)
418Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease
European Respiratory Journal, 1999, 14, 523
8.7116Citations (PDF)
419Resultados de la actuación de una unidad de control de la oxigenoterapia domiciliaria
Archivos De Bronconeumologia, 1999, 35, 33-38
1.411Citations (PDF)
420Patients with Obstructive Sleep Apnea Exhibit Genioglossus Dysfunction that Is Normalized after Treatment with Continuous Positive Airway Pressure
American Journal of Respiratory and Critical Care Medicine, 1999, 159, 1960-1966
8.9163Citations (PDF)
421Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period
European Journal of Clinical Pharmacology, 1998, 54, 203-208
2.020Citations (PDF)
422Does the number of hypopnoeas influence therapy in patients with obstructive sleep apnoea?
Respiratory Medicine, 1998, 92, 1028-1031
2.62Citations (PDF)
423Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 1998, 158, 1664-1668
8.9147Citations (PDF)
424Cytochrome Oxidase Activity and Mitochondrial Gene Expression in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 1998, 157, 1413-1417
8.9129Citations (PDF)
425Noninvasive Ventilation
New England Journal of Medicine, 1998, 338, 1388-1389
34.53Citations (PDF)
426Automobile Accidents in Patients with Sleep Apnea Syndrome: An Epidemiological and Mechanistic Study
American Journal of Respiratory and Critical Care Medicine, 1998, 158, 18-22
8.9360Citations (PDF)
427La biología molecular en el diagnóstico y tratamiento de las enfermedades respiratorias
Archivos De Bronconeumologia, 1998, 34, 256-265
1.43Citations (PDF)
428Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practice
European Heart Journal, 1998, 19, 74-79
2.248Citations (PDF)
429Structure and function relationships of the respiratory muscles
European Respiratory Journal, 1998, 11, 906-911
8.733Citations (PDF)
430Ventilation-Perfusion Mismatch in Patients with Pleural Effusion
American Journal of Respiratory and Critical Care Medicine, 1997, 156, 1205-1209
8.9116Citations (PDF)
431Noninvasive Ventilatory Support After Lung Resectional Surgery
Chest, 1997, 112, 117-121
1.0157Citations (PDF)
432Análisis comparativo de tres tipos de jeringas utilizadas habitualmente para gasometría arterial
Archivos De Bronconeumologia, 1997, 33, 331-334
1.43Citations (PDF)
433A new bronchoscopic technique for the diagnosis of bacterial pneumonia in HIV-positive patients
Respiratory Medicine, 1997, 91, 530-536
2.63Citations (PDF)
434MECHANISMS OF GAS EXCHANGE IMPAIRMENT IN PATIENTS WITH LIVER CIRRHOSIS
Clinics in Chest Medicine, 1996, 17, 49-66
3.479Citations (PDF)
435Long-term Effects of Nasal Intermittent Positive-Pressure Ventilation on Pulmonary Function and Sleep Architecture in Patients With Neuromuscular Diseases
Chest, 1996, 110, 1179-1183
1.0123Citations (PDF)
436Ventilación asistida vía máscara nasal en pacientes hospitalizados en una sala de neumología por descompensación de su obstrucción crónica al flujo aéreo
Archivos De Bronconeumologia, 1996, 32, 373-374
1.40Citations (PDF)
437Trastornos respiratorios durante el sueño en la enfermedad pulmonar obstructiva crónica
Archivos De Bronconeumologia, 1996, 32, 32-39
1.43Citations (PDF)
438Cumplimiento del tratamiento con presión positiva continua nasal (CPAP) en el síndrome de las apneas-hipopneas durante el sueño
Archivos De Bronconeumologia, 1995, 31, 56-61
1.414Citations (PDF)
439Apnoea in Duchenne muscular dystrophy.
Thorax, 1995, 50, 1123-1123
5.64Citations (PDF)
440Effect of sampling site on femoral venous blood gas values
Journal of Applied Physiology, 1994, 77, 2018-2022
2.814Citations (PDF)
441Contribution of multiple inert gas elimination technique to pulmonary medicine. 2. Chronic pulmonary diseases: chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Thorax, 1994, 49, 924-932
5.650Citations (PDF)
442Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up
European Respiratory Journal, 1994, 7, 643-650
8.759Citations (PDF)
443Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy
European Respiratory Journal, 1994, 7, 1403-1408
8.7138Citations (PDF)
444Oxygen conformance of cellular respiration in hepatocytes
American Journal of Physiology - Lung Cellular and Molecular Physiology, 1993, 265, L395-L402
3.267Citations (PDF)
445Effect of pulmonary hypertension on gas exchange
European Respiratory Journal, 1993, 6, 1371-1377
8.740Citations (PDF)
446Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.
Thorax, 1992, 47, 1035-1040
5.667Citations (PDF)
447Ventilación mecánica domiciliaria a presión positiva intermitente por vía nasal
Archivos De Bronconeumologia, 1992, 28, 254-255
1.41Citations (PDF)
448The hepatopulmonary syndrome: new name, old complexities.
Thorax, 1992, 47, 897-902
5.6226Citations (PDF)
449Effects of training on muscle O2 transport at VO2max
Journal of Applied Physiology, 1992, 73, 1067-1076
2.8252Citations (PDF)
450Mechanisms of Abnormal Gas Exchange in Patients with Pneumonia
Anesthesiology, 1991, 75, 782-789
2.263Citations (PDF)
451Mechanisms of Gas-exchange Impairment in Idiopathic Pulmonary Fibrosis
The American Review of Respiratory Disease, 1991, 143, 219-225
3.2261Citations (PDF)
452Ventilation-Perfusion Mismatch after Methacholine Challenge in Patients with Mild Bronchial Asthma
The American Review of Respiratory Disease, 1991, 144, 88-94
3.259Citations (PDF)
453Hypoxic Pulmonary Vasoconstriction and Gas Exchange During Exercise in Chronic Obstructive Pulmonary Disease
Chest, 1990, 97, 268-275
1.0147Citations (PDF)
454Effects of Propranolol on Arterial Oxygenation and Oxygen Transport to Tissues in Patients with Cirrhosis
The American Review of Respiratory Disease, 1990, 142, 306-310
3.245Citations (PDF)
455The lung in patients with cirrhosis
Journal of Hepatology, 1990, 10, 251-257
4.2102Citations (PDF)
456Puncion aspirativa transbronquial y lavado broncoalveolar en el diagnostico del cancer primitivo de pulmon
Archivos De Bronconeumologia, 1989, 25, 93-96
1.43Citations (PDF)
457Lung function in allogeneic bone marrow transplantation recipients
European Respiratory Journal, 1989, 2, 359-365
8.713Citations (PDF)
458Pulmonary function and liver disease
Current Opinion in Gastroenterology, 1988, 4, 609-614
2.013Citations (PDF)
459Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis
European Respiratory Journal, 1988, 1, 510-516
8.764Citations (PDF)
460Oxyhemoglobin affinity in patients with chronic obstructive pulmonary disease and acute respiratory failure
Critical Care Medicine, 1986, 14, 610-613
0.530Citations (PDF)
461Proper Use of Metered Dose Inhalers
Chest, 1985, 88, 159-160
1.06Citations (PDF)
462Hypophosphatemia as a cause of failed weaning
Critical Care Medicine, 1984, 12, 142-143
0.580Citations (PDF)
463Utilidad del lavado broncoalveolar en el diagnostico de la neumonia eosinofila cronica
Archivos De Bronconeumologia, 1984, 20, 207-209
1.42Citations (PDF)
464VP-16 plus cyclophosphamide in the treatment of advanced lung cancer
Cancer, 1983, 51, 385-389
4.011Citations (PDF)
465Sudden Respiratory Arrest from Asthma
Chest, 1983, 83, 933
1.03Citations (PDF)
466Amiloidosis pulmonar. Revision de la literatura
Archivos De Bronconeumologia, 1983, 19, 84-89
1.43Citations (PDF)
467VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M I
Cancer, 1979, 43, 72-77
4.017Citations (PDF)
468Effect of Bronchial Colonisation on Airway and Systemic Inflammation in Stable COPD
COPD: Journal of Chronic Obstructive Pulmonary Disease, 0, , 140924102835001
2.02Citations (PDF)
469Reply to Thomson, to Neder et al ., and to Wouters
American Journal of Respiratory and Critical Care Medicine, 0, 204, 112-112
8.90Citations (PDF)
470Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease
Annals of the American Thoracic Society, 0, 18, 1922-1924
3.42Citations (PDF)
471Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians
Chronic Obstructive Pulmonary Diseases (Miami, Fla ), 0, , 454-476
0.815Citations (PDF)
472Reply to Guo et al .
American Journal of Respiratory and Critical Care Medicine, 0, 207, 1104-1105
8.90Citations (PDF)
473Effectiveness of Inhaler Devices in Adult Asthma and COPD
European Medical Journal Respiratory, 0, , 64-71
0.115Citations (PDF)
474Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine, 0, 208, 1142-1143
8.91Citations (PDF)
475Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities  
Nature Reviews Drug Discovery, 0, 25, 98-115
79.711Citations (PDF)
476The ROME COPD exacerbation proposal works! Time to move forward
American Journal of Respiratory and Critical Care Medicine, 0, 212, 294-296
8.96Citations (PDF)
477Treatable Traits. Why, What, How?
Respiratory Medicine, 0, 249, 108421
2.65Citations (PDF)
478Personalizing COPD care: Phenotypes, endotypes, GETomics, the trajectome, syndemics and treatable traits
Presse Medicale, 0, 55, 104318
2.72Citations (PDF)
479Lessons From the ANTES B+ Study
Archivos De Bronconeumologia, 0, ,
1.41Citations (PDF)
480Radiomic analysis of computed tomography scans in COPD patients relates to different clinical and biological features, and identifies different lung function trajectories during follow-up
ERJ Open Research, 0, 12, 01224-2025
2.50Citations (PDF)
481Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease ( GOLD ) and the Global Initiative for Asthma ( GINA )
Respirology, 0, 31, 135-140
4.02Citations (PDF)
482COPD Management in Primary Care: Underutilisation of Nursing Consultations
Journal of Clinical Nursing, 0, 35, 2744-2754
3.21Citations (PDF)
483Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
European Respiratory Journal, 0, 67, 2502574
8.71Citations (PDF)
484Activation of the inflammasome pathway during exacerbations of COPD
European Respiratory Journal, 0, 38, p420
8.70Citations (PDF)
485Peripheral neutrophil stiffness in severe COPD exacerbations
European Respiratory Journal, 0, 38, p732
8.70Citations (PDF)
486Deployment of integrated care services for patients with long-term oxygen therapy (LTOT): Role of frailty
European Respiratory Journal, 0, 38, p3478
8.70Citations (PDF)
487Role of C reactive protein in non small cell lung cancer staging
European Respiratory Journal, 0, 38, p2806
8.71Citations (PDF)
488LSC 2011 Abstract: BAFF in the interaction between T regulatory and B cells in COPD
European Respiratory Journal, 0, 38, p740
8.70Citations (PDF)
489The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD)
European Respiratory Journal, 0, 38, p875
8.70Citations (PDF)
490Aclidinium bromide in patients with chronic obstructive pulmonary disease: Improvement in health status in ATTAIN
European Respiratory Journal, 0, 38, p877
8.70Citations (PDF)
491Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN
European Respiratory Journal, 0, 38, p874
8.70Citations (PDF)
492The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
European Respiratory Journal, 0, 42, 4851
8.70Citations (PDF)
493Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients
European Respiratory Journal, 0, 42, P608
8.70Citations (PDF)
494In vivo characterization of COPD using endoscopic fibered confocal fluorescence microscopy
European Respiratory Journal, 0, 42, P441
8.70Citations (PDF)
495FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
European Respiratory Journal, 0, 42, P762
8.70Citations (PDF)
496Endoplasmic reticulum stress in bronchial tissue in patients with COPD and lung cancer
European Respiratory Journal, 0, 44, P522
8.70Citations (PDF)
497Pulmonary gas exchange in severe obesity: The effects of bariatric surgery
European Respiratory Journal, 0, 44, P2114
8.70Citations (PDF)
498Lung function tests in severe obese subjects before and one year after bariatric surgery
European Respiratory Journal, 0, 44, P2177
8.70Citations (PDF)
499Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
European Respiratory Journal, 0, 44, P3836
8.70Citations (PDF)
500Automatic alveolar ventilation-targeted NIV mode vs polysomnographic titration of fixed pressure in naive patients with chronic respiratory failure
Sleep, 0, ,
0.90Citations (PDF)
501The EXACERBANTES Study (Exacerbation of Chronic Obstructive Pulmonary Disease According to the ANTES Proposal): Rationale, Goals and Design
Open Respiratory Archives, 0, 8, 100626
0.80Citations (PDF)
502High prevalence of obstructive sleep apnea in patients with Long-COVID
Respiratory Medicine, 0, 257, 108848
2.60Citations (PDF)
503A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD
American Journal of Respiratory and Critical Care Medicine, 0, ,
8.90Citations (PDF)